![Logo for Uniphar plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fdbb10-2023-12-20-08-13-31.png&w=256&q=100)
Uniphar Investor Relations Material
Latest events
![Logo for Uniphar plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fdbb10-2023-12-20-08-13-31.png&w=128&q=100)
H1 2024
Uniphar
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Uniphar plc
Access all reports
Uniphar Public Limited Company is a diversified healthcare services provider, operating mainly in the Republic of Ireland, the United Kingdom, and on an international scale. The company functions through three primary divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. In the Commercial & Clinical segment, Uniphar offers outsourced sales, marketing, and multichannel account management services to pharmaco-medical manufacturers, alongside distribution and support services to medical device manufacturers. The Product Access division delivers services that facilitate access to pharmaco-medical products and treatments, establishing vital connections between manufacturers and healthcare stakeholders, as well as providing bespoke distribution partnerships for pharmaceutical partners. The Supply Chain & Retail division is involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary surgeons, and operates a network of pharmacies under various brands. Additionally, it provides a range of support services including pharmacy support, specialist nursing, infusion, medical device distribution, healthcare technology, data intelligence, consultancy, pharmaceutical advisory, medical affairs, online pharmacy, and product fostering services. The company is headquartered in Dublin, Ireland, and its shares are listed on the Irish Stock Exchange.
Key slides for Uniphar plc
![Investment Case
St](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Funiphar-plc-h1-2024-4434124fc437ba5b%2F24.png&w=3840&q=75)
![Logo for Uniphar plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fdbb10-2023-12-20-08-13-31.png&w=128&q=100)
H1 2024
Uniphar plc
![9
Divisional strat](/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Funiphar-plc-h1-2024-4434124fc437ba5b%2F9.png&w=3840&q=75)
![Logo for Uniphar plc](/_next/image?url=https%3A%2F%2Ffiles.quartr.com%2Fcompany-logos%2Fdbb10-2023-12-20-08-13-31.png&w=128&q=100)
H1 2024
Uniphar plc
Latest articles
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2Fbbbaafadba%2Fpontis-dackmo_strong-opinions-loosely-held.png&w=3840&q=75)
Strong Opinions, Loosely Held: Pontus Dackmo on Flexibility and Market Psychology
After a two-decade career in finance, Pontus Dackmo co-founded Protean Funds Scandinavia in 2022, where he now serves as CEO and Investment Manager.
4 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F7455f6afd1%2Fnovo-nordisk_the-danish-pharmaceutical-titan.png&w=3840&q=75)
Novo Nordisk: The Danish Pharmaceutical Titan Revolutionizing Global Healthcare
Novo Nordisk's rise to becoming Europe's largest company, reshaping global healthcare and Denmark's economy.
5 Sep 2024
![Key](/_next/image?url=https%3A%2F%2Fa.storyblok.com%2Ff%2F182663%2F2000x1125%2F5533bee49f%2Fthe-toyota-way.png&w=3840&q=75)
The Toyota Way: Revolutionizing Global Manufacturing
Explore how Toyota's Lean Manufacturing and Kaizen principles revolutionized production and quality, setting global benchmarks for excellence.
2 Sep 2024
Ticker symbol
UPR
Country
🇮🇪 Ireland